NO20065781L - Inhibitorer av 11-beta-hydroksysteroiddehydrogenase type 1. - Google Patents

Inhibitorer av 11-beta-hydroksysteroiddehydrogenase type 1.

Info

Publication number
NO20065781L
NO20065781L NO20065781A NO20065781A NO20065781L NO 20065781 L NO20065781 L NO 20065781L NO 20065781 A NO20065781 A NO 20065781A NO 20065781 A NO20065781 A NO 20065781A NO 20065781 L NO20065781 L NO 20065781L
Authority
NO
Norway
Prior art keywords
hydroxysteroid dehydrogenase
dehydrogenase type
inhibitors
beta
enzyme
Prior art date
Application number
NO20065781A
Other languages
English (en)
Norwegian (no)
Inventor
Guolin Cai
Qi Huang
Chester Chenguang Yuan
Meredith Williams
Christopher H Fotsch
Qingyian Liu
Martin Henriksson
Evert Homan
Lars Johansson
Jerk Vallgarda
Eric Bercot
Aiwen Li
Randall W Hungate
Christopher Tegley
Jean David St
Nianhe Han
Michael D Bartberger
Georg A Moniz
Matthew J Frizzle
Original Assignee
Biovitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0401324A external-priority patent/SE0401324D0/xx
Priority claimed from SE0402509A external-priority patent/SE0402509D0/xx
Priority claimed from PCT/US2005/018081 external-priority patent/WO2005116002A2/en
Application filed by Biovitrum Ab filed Critical Biovitrum Ab
Publication of NO20065781L publication Critical patent/NO20065781L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/42Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20065781A 2004-05-24 2006-12-13 Inhibitorer av 11-beta-hydroksysteroiddehydrogenase type 1. NO20065781L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE0401324A SE0401324D0 (sv) 2004-05-24 2004-05-24 New compounds
SE0402509A SE0402509D0 (sv) 2004-10-15 2004-10-15 New compounds
US65077705P 2005-01-31 2005-01-31
PCT/US2005/018081 WO2005116002A2 (en) 2004-05-24 2005-05-24 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1

Publications (1)

Publication Number Publication Date
NO20065781L true NO20065781L (no) 2007-02-08

Family

ID=41717469

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065781A NO20065781L (no) 2004-05-24 2006-12-13 Inhibitorer av 11-beta-hydroksysteroiddehydrogenase type 1.

Country Status (10)

Country Link
KR (1) KR101296408B1 (es)
CR (2) CR8771A (es)
EC (1) ECSP067108A (es)
HK (1) HK1096095A1 (es)
HR (1) HRP20060456A2 (es)
IL (1) IL179167A (es)
MA (1) MA28662B1 (es)
MX (1) MXPA06013657A (es)
NO (1) NO20065781L (es)
NZ (1) NZ552284A (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ302691B6 (cs) 1998-07-08 2011-09-07 Sanofi - Aventis Deutschland GmbH N-Arylamidová sloucenina, zpusob její prípravy, farmaceutický prostredek tuto slouceninu obsahující, tato sloucenina pro použití jako aktivátor a pro použití k terapii nebo profylaxi

Also Published As

Publication number Publication date
NZ552284A (en) 2010-01-29
CR8771A (es) 2007-07-24
ECSP067108A (es) 2007-05-30
CR20120420A (es) 2012-09-14
IL179167A (en) 2012-01-31
HK1096095A1 (en) 2007-05-25
MA28662B1 (fr) 2007-06-01
IL179167A0 (en) 2007-03-08
KR101296408B1 (ko) 2013-08-13
HRP20060456A2 (en) 2007-03-31
KR20070058382A (ko) 2007-06-08
MXPA06013657A (es) 2007-11-07

Similar Documents

Publication Publication Date Title
TW200609227A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
ATE469136T1 (de) Inhibitoren von 11-beta- hydroxysteroiddehydrogenase typ 1
NO20071137L (no) Nye piperidinderivater for behandling av depresjon
NO20063928L (no) Substituerte kinolinforbindelser
NO20042161L (no) Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1
EA200870216A1 (ru) Амидо соединения и их применение в качестве лекарственных средств
EA200870019A1 (ru) Лактамовые соединения и способы их применения
EA200700096A1 (ru) Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии
WO2005075471A3 (en) Thiazol-compounds as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
NO20056010L (no) Biaryloksymetylaren-karboksylsyrer
MX2007010532A (es) Derivados de amida de acido 1-sulfonil-piperidina-3-carboxilico como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa para el tratamiento de diabetes mellitus tipo ii.
DK1807072T3 (da) Cycloalkyllactamderivater som inhibitorer af 11-beta-hydroxysteroid-dehydrogenase 1
SE0001899D0 (sv) New compounds
WO2004033455A3 (en) Hemisuccinate salts of heterocyclic dpp-iv inhibitors
NO20072608L (no) Biaryloksymetylarenkarboksylsyrer
NO20080164L (no) N-(pyridin-2-yl)-sulfonamidderivater
NO20054852L (no) GFAT inhibitorer
NO20065904L (no) Terapeutiske forbindelser
NO20065880L (no) 3-Amino-l-arylpropylindoler som monoamin-gjenopptagelsesinhibitor
NO20054382L (no) Diarylsykloalkylderivater, deres fremstilling og deres anvendelse som legemiddel
NO20075113L (no) Proteinkinaseinhibitorer
NO20073830L (no) Medikamenter for behandling eller forebygging av fibrotiske sykdommer
ATE432260T1 (de) Pyridinderivate als pkc-theta-hemmer
NO20052699L (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser.
NO20080394L (no) N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application